U.S., Jan. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07340814) titled 'A Long-term Follow-up Study of Patients Who Received MB-105' on Jan. 06.
Brief Summary: This study is to fulfil the regulatory requirement for 15-year follow-up for patients treated with MB-105 in any study
Study Start Date: Feb. 27
Study Type: OBSERVATIONAL
Condition:
Any Patient Treated With MB-105
Intervention:
BIOLOGICAL: MB-105
This is an observational study with no study product administered because it is the LTFU study for patients who received the product in another study
Recruitment Status: NOT_YET_RECRUITING
Sponsor: March Biosciences Inc
Disclaimer: Curated by HT Syndication....